Milan J. Sonneveld - Publications

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 19, 2026

Editorial: Using HBcrAg and HBsAg Kinetics to Optimise Monitoring After Nucleo(s)tide Analogue Withdrawal.

Journal: Alimentary pharmacology & therapeutics

Published: April 08, 2026

Reply to: "Is partial cure a realistic endpoint for novel hepatitis B therapy?"

Journal: Journal of hepatology

Published: February 27, 2026

Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort.

Journal: Journal of hepatology

Published: November 24, 2025

Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction-Do Existing Scores Clear the Bar? Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: September 30, 2025

Individualising endpoints in chronic HBV treatment: HBsAg loss and beyond.

Journal: Journal of hepatology

Published: September 15, 2025

Clinical Utility and Diagnostic Accuracy of the GAAD Score in Non-cirrhotic Patients With Focal Liver Lesions.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 15, 2025

HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).

Journal: Gut

Published: July 04, 2025

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt.

Journal: Alimentary pharmacology & therapeutics

Published: May 23, 2025

Association Between Sustained Virological Response and Adverse Liver-Related Events in Patients With Decompensated Hepatitis C Virus Cirrhosis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: May 01, 2025

Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Alimentary pharmacology & therapeutics

Published: April 10, 2025

Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis.

Journal: JHEP reports : innovation in hepatology

Published: March 24, 2025